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Impact of copper and iron binding properties on
the anticancer activity of 8-hydroxyquinoline
derived Mannich bases†
Veronika F. S. Pape, ‡a Nóra V. May, b G. Tamás Gál,b István Szatmári,c
Flóra Szeri, §a Ferenc Fülöp,c Gergely Szakács *a,d and Éva A. Enyedy *e
The anticancer activity of 8-hydroxyquinolines relies on complex formation with redox active copper and
iron ions. Here we employ UV-visible spectrophotometry and EPR spectroscopy to compare proton dis-
sociation and complex formation processes of the reference compound 8-hydroxyquinoline (Q-1) and
three related Mannich bases to reveal possible correlations with biological activity. The studied derivatives
harbor a CH2–N moiety at position 7 linked to morpholine (Q-2), piperidine (Q-3), and chlorine and
ﬂuorobenzylamino (Q-4) substituents. Solid phase structures of Q-3, Q-4·HCl·H2O, [(Cu(HQ-2)2)2]·
(CH3OH)2·Cl4·(H2O)2, [Cu(Q-3)2]·Cl2 and [Cu(HQ-4)2(CH3OH)]·ZnCl4·CH3OH were characterized by
single-crystal X-ray diﬀraction analysis. In addition, the redox properties of the copper and iron complexes
were studied by cyclic voltammetry, and the direct reaction with physiologically relevant reductants
(glutathione and ascorbic acid) was monitored. In vitro cytotoxicity studies conducted with the human
uterine sarcoma MES-SA/Dx5 cell line reveal the signiﬁcant cytotoxicity of Q-2, Q-3, and Q-4 in the sub-
to low micromolar range (IC50 values 0.2–3.3 μM). Correlation analysis of the anticancer activity and the
metal binding properties of the compound series indicates that, at physiological pH, weaker copper(II) and
iron(III) binding results in elevated toxicity (e.g. Q4: pCu = 13.0, pFe = 6.8, IC50 = 0.2 μM vs. Q1: pCu =
15.1, pFe = 13.0 IC50 = 2.5 μM). Although the studied 8-hydroxyquinolines preferentially bind copper(II)
over iron(III), the cyclic voltammetry data revealed that the more cytotoxic ligands preferentially stabilize
the lower oxidation state of the metal ions. A linear relationship between the pKa (OH) and IC50 values of
the studied 8-hydroxyquinolines was found. In summary, we identify Q-4 as a potent and selective anti-
cancer candidate with signiﬁcant toxicity in drug resistant cells.
Introduction
The broad pharmacological activity of 8-hydroxyquinoline
(Q-1, Chart 1) and its derivatives has been exploited in several
medicinal applications ranging from antineurodegenerative,
Chart 1 Structures of the reference compound 8-hydroxyquinoline
(Q-1) and its derivatives (Q-2, Q-3, and Q-4) reported in this work in
their neutral form.
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tribution diagrams and cyclic voltammograms for the studied complexes. NMR
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CIF or other electronic format see DOI: 10.1039/c8dt03088j
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anti-inflammatory and antimicrobial to anticancer thera-
pies.1,2 In all of these applications, the therapeutic eﬀect of
8-hydroxyquinolines is believed to rely on metal chelation.
Indeed, the (N,O) donor set of the planar, heterocyclic scaﬀold
possesses a high aﬃnity for various transition metal ions. For
example, clioquinol (5-chloro-7-iodo-8-hydroxyquinoline, CQ),
a lipophilic derivative of Q-1, has been explored as a treatment
for Alzheimer’s disease based on its ability to disrupt the inter-
action between zinc(II) and copper(II) ions and the Aβ peptide
in the brain.3,4 CQ and numerous other 8-hydroxyquinoline
derivatives were reported to exhibit a remarkable anticancer
eﬀect. The anticancer activity of 8-hydroxyquinolines is also
related to complexation with endogenous metals, above all the
redox active copper and iron ions.5–7 Despite continuous inter-
est in novel 8-hydroxyquinolines as candidate anticancer
agents, relatively little is known about their exact mechanism
of toxicity. Studies have suggested several alternative models,
including lysosomal disruption, inhibition of proteasome or
histone deacetylase, inhibition of angiogenesis, or the inhi-
bition of ribonucleotide reductase.8–10 Labile iron and copper
pools in the cytoplasm represent only rather low concen-
trations under healthy conditions, as most of these metal ions
are bound to proteins.11,12 However, the concentration of
labile metal ions may be significantly increased in cancer
cells.13 CQ can also act as an ionophore, inducing the transfer
of metal ions across biological membranes, either in or out of
cells.10 The antitumor activity of 8-hydroxyquinolines may also
be linked to the toxicity of their metal complexes, as shown
for copper(II),6,14 ternary ruthenium(II),15 half-sandwich
organoruthenium,16–19 organorhodium,16 platinum(II)20 and
gallium(III).21,22
Mannich bases of 8-hydroxyquinolines were reported to
possess high potency against human cancer cells,23,24 and our
meta-analysis of the cytotoxicity of various 8-hydroxyquino-
lines revealed the importance of the CH2–N subunit at position
7 for cytotoxicity.25–27 In this study we have chosen three
8-hydroxyquinoline derivatives in which the crucial CH2–N
building block is retained. Morpholine (7-(morpholinomethyl)
quinolin-8-ol, Q-2) and piperidine (7-(piperidin-1-ylmethyl)qui-
nolin-8-ol, Q-3) moieties are introduced at position 7 (Chart 1)
to decrease the hydrophobic character of the reference com-
pound Q-1. To include a compound with a more lipophilic
character to the study, Q-4 was developed, bearing a chlorine
at position 5 and a fluorobenzylamino substituent at position
7 (5-chloro-7-((2-fluorobenzylamino)methyl)quinolin-8-ol, Q-4,
Chart 1).
In this work we characterize the eﬀect of these derivatiza-
tions on the cytotoxicity, proton dissociation processes,
lipophilicity, copper(II) and iron(III) binding abilities and also
study the redox properties of the relevant metal complexes to
establish the relationship between the determined thermo-
dynamic parameters and the biological activity of the com-
pounds. Correlation analysis exploring the relationship
between physico-chemical and biological properties provides
an opportunity to better understand the mechanism of action
of these compounds. Based on quantitative relationship ana-
lyses between chemical structures and bioactivity, between a
set of thermodynamic parameters and toxicity, more reliable
structure activity predictions can be made. Elegant examples
of these types of correlation studies were shown for e.g. poly-
oxometalates regarding their antibacterial activity,28 or for
the antitumor and antiangiogenic eﬀect of half-sandwich
Ru(η6-p-cymene) and Ir(η5-C5Me5) benzimidazole complexes.29
Results and discussion
Synthesis and characterization of the 8-hydroxyquinoline
derived Mannich bases
Q-1 is a commercially available compound, while Q-2 and Q-3
were obtained from the National Cancer Institute’s
Developmental Therapeutics Program (Chart 1).27 As shown in
Scheme 1, Q-4 was synthesized by coupling 5-chloro-8-hydroxy-
quinoline with 2-fluorobenzylamine in the presence of para-
formaldehyde via a modified Mannich reaction under microwave
conditions. The formed [1,3]oxazino[5,6-h]quinolone derivative
was isolated by crystallization from an n-hexane : ethyl acetate
mixture and converted to the desired product as Q-4·HCl in
ethanolic hydrogen chloride in excellent yield. NMR spectra
were in agreement with the expected structures, enabling the
assignment of all 1H and 13C resonances. The purity of
Q-4·HCl was further confirmed by elemental analyses.
The structures of Q-3 and Q-4·HCl·H2O were established by
single crystal X-ray diﬀraction (Fig. 1). Crystal data and struc-
ture refinement parameters of the crystals are given in
Table S1;† selected bond distances and angles are listed in
Scheme 1 Two-step synthesis of 5-chloro-7-((2-ﬂuorobenzyl-amino)
methyl)quinolin-8-ol Q-4, starting from 5-chloro-8-hydroxyquinoline
via a modiﬁed Mannich reaction in ethanol (EtOH) at 100 °C, under
microwave (MW) conditions, followed by an acidic cleavage of the
dihydro-[1,3]-oxazine ring with HCl in ethanolic solution.
Fig. 1 ORTEP views of Q-3 (a) and Q-4·HCl·H2O (b) at the 30% prob-
ability level of displacement ellipsoids. Blue lines indicate the suggested
intramolecular hydrogen bonds. Selected bond distances and bond
angles are listed in Tables S2 and S4.†
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Tables S2 and S4.† Q-3 crystallized in its neutral form in the
orthorhombic crystal system, in the space group P212121,
without solvent inclusion.
The molecular structure is stabilized by the O1–H1O⋯N10
intramolecular hydrogen bond. The crystal structure is stabil-
ized by weak C–H⋯O and C–H⋯π interactions with the partici-
pation of the piperidine protons (Fig. S1 and Tables S2, S3†).
Q-4 crystallized in its protonated form with Cl− counter ions
and a water molecule in the triclinic crystal system, in the
space group P1ˉ. The conformation is stabilized by a weak inter-
molecular interaction between O1 and one of the amino
protons. The neighboring molecules are connected by O–H⋯N
and C–H⋯O hydrogen bonds, and π⋯π (oﬀ-centered parallel
stacking) interactions (Fig. S1, S2 and Tables S3, S5†).
In vitro toxicity of Q-1 and its Mannich base derivatives
against a cancer cell line and primary hepatocytes
The in vitro cytotoxic activity of compounds Q-1 to Q-4 was
determined in the human uterine sarcoma MES-SA/Dx5 cell
line and in primary hepatocytes (Table 1). The compounds
demonstrated marked cytotoxic activity in the micromolar
and submicromolar concentration range in the drug resistant
human uterine sarcoma MES-SA/Dx5 cell line, increasing in
the following order Q-2 < Q-1 < Q-3 < Q-4. Notably, Q-3 and
Q-4 possess even stronger cytotoxic activity than the FDA
approved anticancer agent doxorubicin. To exclude non-
specific toxic eﬀects related to the multiple targets of metal
chelators,30 primary hepatocytes were also included in the
study. Compared to doxorubicin, the newly investigated com-
pounds displayed a manifold higher selectivity towards cancer
cells (Table 1). Due to the high proliferation rate, malignant
cancer cells show increased reliance on metal ions, which are
required e.g. as co-factors in enzymes catalyzing essential
steps in DNA-synthesis, as well as for cell cycle progression
and cellular growth.31–34 For example, the rate limiting step in
DNA synthesis is the reduction of ribonucleotides, which is
catalyzed by the iron dependent enzyme ribonucleotide
reductase (RR).35,36 Thus, selective toxicity of the studied com-
pounds to the human uterine sarcoma cells over hepatocytes
might be the result of the altered metal homeostasis of the
cancerous cells.
Proton dissociation processes of the studied
8-hydroxyquinolines
The proton dissociation constant (Ka) is a key physico-chemi-
cal parameter influencing the pharmacokinetic properties of
the compounds. Determination of the pKa value allows the
estimation of the distribution of the chemical forms of the
molecule in the various protonation states at a given pH. As
the pKa values of the reference compounds Q-1 and Q-3 are
available, although for Q-3 under diﬀerent conditions,16,37 we
determined the pKa values of Q-2, Q-3 and Q-4 by UV-visible
(UV-Vis) spectrophotometric titrations in an aqueous solution.
This method requires lower concentrations as compared to
pH-potentiometry, which are compatible with the limited
water-solubility of the compounds. The UV-Vis spectra of all
ligands recorded in the pH range 2 to 11.5 show characteristic
spectral changes upon deprotonation processes.
Representative spectra for Q-2, as well as the molar absor-
bance spectra of individual ligand species in the diﬀerent pro-
tonated forms are shown in Fig. 2. The recorded absorbance
Fig. 2 UV-Vis absorption spectra of Q-2 (a) recorded at diﬀerent pH
values in aqueous solution and the calculated molar absorption spectra
of the individual ligand species (b). (cQ-2 = 50 µM; T = 25.0 °C; I = 0.20
M KCl; l = 2 cm).
Table 1 In vitro cytotoxicity (expressed as IC50) of the studied compounds in the human uterine sarcoma MES-SA/Dx5 cell line and in primary
hepatocytesa
IC50/μM Q-1 Q-2 Q-3 Q-4 Doxorubicin
MES-SA/Dx5 2.46 ± 0.69 3.27 ± 0.39 0.86 ± 0.26 0.20 ± 0.06 2.13 ± 0.65
Primary hepatocytes 115 ± 18 243 ± 69 163 ± 35 40.4 ± 8.9 2.14 ± 1.11
aDetermined by means of the MTT assay after exposure for 72 h. Values are means ± standard deviations obtained from at least three indepen-
dent experiments.
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spectra were deconvoluted resulting in the pKa values of the
compounds and the molar absorbance spectra of the various
species (Table S6†). The pKa values were assigned to the
particular moieties by careful analysis of the spectral changes
(Scheme 2). The deprotonation processes of Q-1 are well-
described in the literature,16,37 and pK1 and pK2 values corres-
pond to the deprotonation of the quinolinium-NH+ and the
phenolic-OH moieties, respectively, as indicated in Scheme 2.
Values obtained for Q-3 are in good agreement with those
reported in the presence of KNO3 instead of KCl.
16
The most pronounced spectral changes are linked to the
deprotonation of the hydroxyl functional group. The emerging
strong bands with higher λmax values originate from the more
extended conjugated π-electron system in the deprotonated
form.16,37 In comparison with the 8-hydroxyquinoline scaﬀold
(Scheme 2), the morpholino-substituent in the 7-position in
Q-2 increases the pKa value of the phenolic-OH by almost one
order of magnitude, possibly due to the formation of a hydro-
gen bond between the OH and the morpholine-N in the HL
form of the ligand, which hinders deprotonation. In contrast,
the protonated (thus positively charged) amine moieties of the
piperidine of Q-3 and of the benzylamine in the case of Q-4
decrease the proton dissociation constants of the OH group by
2.5 and 4.4 orders of magnitude, respectively, as compared to
Q-1. These results are consistent with the lower pKa values
reported for numerous hydroxamic and carboxylic acids due to
the electron withdrawing eﬀect of the protonated piperidinium
moiety.38 As confirmed by single crystal X-ray diﬀraction
analysis of the solid compounds Q-3 and Q-4·HCl·H2O
(vide supra), possible hydrogen bond formations between the
phenolate and the piperidinium moiety of Q-3 (in the zwitter-
ionic L form) can additionally contribute to the diminished
pKa values due to the stabilization of the conjugate base.
Intramolecular hydrogen bonding is also probable in the HL
form of Q-4 between the phenolate and the protonated
benzylamine moieties. The pKa of the OH group in Q-4 (pK1) is
also aﬀected by the electron withdrawing eﬀects of the chloro-
substituent.
pKa values assigned to the deprotonation of the quinoli-
nium-NH+ moiety of the R7-substituted ligands (pK1 for Q-2 and
Q-3) were found to be considerably lower compared to that of
Q-1 as a consequence of the electron withdrawing eﬀect of the
protonated methylene-amine groups in the Mannich bases. In
Q-4 the deprotonation of this moiety could not be observed
under the applied experimental conditions, since it most prob-
ably takes place at lower pH (<2) due to the additional negative
inductive eﬀect of the halogen atom (the predicted pKa value for
the quinolinium-NH+ moiety in Q-4 is 0.98).39
Based on smaller spectral alterations further pKa values
could be assigned corresponding to the deprotonation pro-
cesses of the non-coordinating nitrogens, such as the morpho-
linium-NH+ of Q-2 and the benzylamino-NH+ of Q-4.
Deprotonation of the piperidinium-NH+ of Q-3 most probably
takes place only at strongly basic pH (pKa > 11.5).
On the basis of the obtained pKa values, species distri-
bution was calculated at pH 7.4 (Scheme 2). Thus, the neutral
forms of these compounds predominate at physiological pH;
however Q-3 and Q-4 are mostly present in their zwitterionic
L and HL forms, respectively. The lipophilicity of the com-
pounds was characterized by the n-octanol/water distribution
coeﬃcients at pH 7.4 (logD7.4 values in Scheme 2). These data
revealed that while the introduction of the aliphatic methylene
amines in position R7 of Q-2 and Q-3 increases the hydrophilic
character of the ligands in comparison with the unsubstituted
Scheme 2 Proton dissociation steps of the studied 8-hydroxyquinolines and their pKa values. Predominant species and n-octanol/water distri-
bution coeﬃcients (logD7.4) determined at pH 7.4. (T = 25 °C, I = 0.20 M (KCl))
aData taken from ref. 43.
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scaﬀold Q-1, the additional benzyl moiety on the methylene
amine in R7 and the halogen substituent in R5 significantly
increase the lipophilicity of Q-4.
Complex formation of the studied 8-hydroxyquinolines with
iron(III) and copper(II) in solution
The anticancer activity of 8-hydroxyquinolines may be related
to the formation of (redox active) metal complexes with essen-
tial ions such as iron and copper7,40 Therefore, we investigated
complex formation of Q-2 to Q-4 with two physiologically rele-
vant metal ions (iron(III) and copper(II)), in order to reveal a
possible relationship between the metal binding ability of
these ligands and their cytotoxicity. Results were compared to
data reported for Q-1.41,42
Complexation of the 8-hydroxyquinoline derived Mannich
bases with iron(III) and copper(II) was studied by UV-Vis
spectrophotometry. During titrations with both metal ions
the absorbance values tend to decrease at pH ≳ 8. In the
case of iron(III), hydrolysis of the metal ion may suppress
complex formation at alkaline pH values, whereas neutral
copper(II) complexes precipitate at pH ≳ 9 (Fig. S3† for Q-2 and
Q-4 complexes). Given these possible artefacts, evaluation was
restricted to data collected at pH < 8. Spectral changes upon
complexation with iron(III) detected in the 350–750 nm wave-
length range were the most useful for the calculations of the
overall stability constants, since bands located in this range
are relatively well-separated from the ligand bands (see the
representative spectra for Q-3 in Fig. 3).
The stoichiometries of the metal complexes and the overall
stability constants (β) furnishing the best fits to the experi-
mental data are shown in Table 2.
The molar absorbance spectra of the individual metal com-
plexes were also computed (see λmax and molar absorptivity
values in Table S7†). As expected, mono and bis complexes are
formed with both metal ions, while tris complexes could also
be detected with iron(III). In the case of Q-2 and Q-4, further
protonated complexes were formed, in which the protons were
attributed to the non-coordinating protonated morpholinium
and secondary amine moieties, respectively (Table 2).
Based on the overall stability constants (Table 2), concen-
tration distribution diagrams were computed at various metal-
to-ligand ratios (exemplarily diagrams are shown for 5 µM
ligand concentration at pH 7.4 in Fig. S4†). These data reveal
the diﬀerent speciation of the four ligands at physiological pH.
Complexation of iron(III) with Q-1 and Q-2 predominantly
results in tris-ligand complexes, while with Q-3, the formation
of the bis-complex is more pronounced. In the iron(III)−Q-4
system, mono and protonated bis complexes co-exist at pH 7.4.
Notably, the formation of tris complexes is not observed even
at a 1 : 3 metal-to-ligand ratio, most probably due to steric
reasons. In the case of copper(II) complexation, at a 1 : 2 metal-
to-ligand ratio, the coordination sphere of the metal ion is
likely to be saturated in the physiologically relevant pH range,
as bis complexes are formed almost exclusively under these
conditions.
Fig. 3 UV-Vis absorption spectra recorded for the iron(III) – Q-3 (1 : 3) system at diﬀerent pH values (a) and the calculated UV-Vis molar absorption
spectra of the various complexes (b). (cQ-3 = 50 μM; T = 25.0 °C; I = 0.20 M KCl; l = 2 cm).
Table 2 Logarithm of the overall stability constants (log β) of the
copper(II) and iron(III) complexes of ligands Q-2 to Q-4 determined by
UV-vis spectrophotometric titrations and pM values calculated at pH
7.4. Data for Q-1 are also shown for comparison. (Charges of the com-
plexes are omitted for clarity. L is neutral for Q-3 and singly negatively
charged for Q-1, Q-2 and Q-4.) (T = 25 °C, I = 0.20 M (KCl))
Q-1 Q-2 Q-3 Q-4
Log β [FeLH] — 19.80 ± 0.04 — 18.46 ± 0.04
Log β [FeL] 13.69a 16.90 ± 0.04 11.11 ± 0.02 14.31 ± 0.05
Log β [FeL2H2] — — — 34.44 ± 0.04
Log β [FeL2H] — 35.18 ± 0.04 — 28.50 ± 0.06
Log β [FeL2] 26.3
a — 20.32 ± 0.03 —
Log β [FeL3H] — 49.03 ± 0.03 — —
Log β [FeL3] 36.9
a 42.49 ± 0.03 25.42 ± 0.07 —
pMc 21.1 21.1 16.0 14.8
pM*d 13.0 13.0 8.0 6.8
Log β [CuLH] — — — 16.87 ± 0.03
Log β [CuL] 12.1b 16.54 ± 0.04 10.6 ± 0.1 10.96 ± 0.07
Log β [CuL2H2] — — — 32.54 ± 0.06
Log β [CuL2H] — 34.67 ± 0.04 — 26.94 ± 0.06
Log β [CuL2] 23.0
b 27.5 ± 0.1 19.4 ± 0.1 —
pMc 15.1 17.4 14.9 13.0
aData taken from ref. 41. bData taken from ref. 42. c pM = −log[M] cal-
culated at pH = 7.4, cM = 1 μM; cL = 10 μM. d pM* = −log([Fe] + i ×
∑[Fei(OH)j]) calculated at pH = 7.4, cM = 1 μM; cL = 10 μM.
Paper Dalton Transactions
17036 | Dalton Trans., 2018, 47, 17032–17045 This journal is © The Royal Society of Chemistry 2018
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 0
7 
N
ov
em
be
r 2
01
8.
 D
ow
nl
oa
de
d 
on
 1
/8
/2
01
9 
4:
16
:4
1 
PM
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n-
N
on
Co
m
m
er
ci
al
 3
.0
 U
np
or
te
d 
Li
ce
nc
e.
View Article Online
The overall stability constants of the complexes cannot be
compared directly owing to the diﬀerent basicities of the
ligands and the number of dissociable protons. However, the
stability constants for the iron(III) species are generally higher
than those of the corresponding copper(II) complexes, the sig-
nificantly diﬀerent extent of hydrolysis of these metal ions
should also be taken into consideration when the solution
stabilities are compared. Therefore, in order to compare the
metal binding ability of the four investigated 8-hydroxyquino-
lines adequately, pM values (negative decadic logarithm of the
equilibrium concentration of the unbound metal ion) were
computed at pH 7.4 (Table 2). In the case of iron(III), the for-
mation of hydroxido species was also taken into account (pM*
values in Table 2). At pH 7.4, the iron binding capacity of the
investigated ligands follows the order Q-1 ∼ Q-2 > Q-3 > Q-4,
and a similar trend (Q-2 > Q-1 > Q-3 > Q-4) was obtained for the
copper(II) complexes. A comparison of the pM (of copper(II))
and pM* (of iron(III)) values indicates that at pH 7.4, the studied
ligands preferentially bind copper(II) over iron(III).
To further investigate the coordination modes of the copper(II)
complexes in solution, electron paramagnetic resonance (EPR)
spectroscopic measurements were performed.
EPR spectra were recorded at room temperature for samples
containing copper(II) and the investigated ligands (deproto-
nated with one equivalent of NaOH) in equimolar concen-
trations and at two-fold ligand excess (Fig. 4). Dimethyl sulfox-
ide (DMSO) was used as a solvent in which the complexes are
soluble in the mM concentration range. The measured spectra
could be deconvoluted into the individual spectra of mono-
and bis complexes (and free copper(II)). Notably, the [CuL2]
and [CuL2H] complexes could not be distinguished, as side
chain deprotonations have a negligible impact on the EPR
spectra. The EPR data indicate that the formation of the mono
complexes seems to be more pronounced in DMSO than in the
aqueous solution in case of Q-1 and Q-4. Additionally, the frac-
tion of the bis complex is much lower for Q-4 as compared to
the other ligands, most probably due to steric reasons. The iso-
tropic EPR parameters obtained by the simulation of room
temperature spectra are shown in Table 3.
The go values of the copper(II) complexes support a similar
bidentate (N,O−) 8-quinolinolato coordination mode in all
complexes. It is worth noting that the go constant of the mono
complex of Q-4 is higher compared to those of the complexes
of the other 3 ligands, indicating a somewhat weaker ligand
field.
EPR spectra were also recorded at 77 K in methanol and in
toluene. Interestingly, these EPR spectra revealed that while
for Q-1 and Q-3 the bis complexes form monomers, for Q-2
and Q-4, additional dimeric species were detectable (Fig. S5,
Table S8†) in the frozen samples. A doublet peak detected at
around 3000 and 3500 G and the half-field signal at 1500 G
unambiguously show the appearance of a coupled-spin system
(S = 1), which can be established by two neighboring copper(II)
centers. From the simulation of the spectra the orientation of
the copper(II) centers can be calculated (polar angles: χ =
28.5°, ψ = −5.0°), showing that one center is above the other. A
copper–copper distance of 3.88 Å was calculated from the
dipolar coupling by using the point-dipole approach. These
results are in good agreement with the obtained X-ray crystallo-
graphic results (vide infra) where χ = 35.1° and ψ = 0° could be
measured for Q-2 and χ = 30.6° and ψ = 0° for Q-4, and the
copper–copper distances are 3.3935(7) Å and 3.8354(8) Å
respectively. From this result we conclude that the bis
complexes of Q-2 and Q-4 preferably form dimers in frozen
solution as well as in the solid state.
Solid phase characterization of the copper(II) complexes of the
studied 8-hydroxyquinolines
Single crystals suitable for X-ray crystallography were obtained
from methanolic solution in the case of the copper(II) com-
plexes of Q-2, Q-3 and Q-4 as [(Cu(HQ-2)2)2]·(CH3OH)2·
Cl4·(H2O)2, [Cu(Q-3)2]·Cl2 and [Cu(HQ-4)2(CH3OH)]·ZnCl4·
CH3OH (Fig. 5). Crystal data and structure refinement para-
meters are given in Table S1.† Selected bond distances and
angles are specified in the legend of Fig. 5, while packing
Fig. 4 Experimental (black) and simulated (grey) room temperature EPR
spectra recorded for the copper(II) – ligand systems (Q-1–Q-4) in DMSO
at cCu(II) = 2 mM in the presence of one (a) or two (b) equivalents of the
ligand. Concentration ratios of the mono and bis complexes obtained
from the simulation are indicated in the spectra.
Table 3 Isotropic EPR parameters obtained by the simulation of room
temperature EPR spectra recorded in DMSOa
Ligand Complex go Ao/G aN/G
DMSO Cu(DMSO) 2.170 35 —
Q-1 Mono 2.144 59 9
Bis 2.116 73 11, 11
Q-2 Mono 2.142 57 10
Bis 2.113 71 11, 11
Q-3 Mono 2.144 59 8
Bis 2.114 72 11, 11
Q-4 Mono 2.152 68 9
Bis 2.113 63 11, 11
a The experimental error is ±0.001 for go, ±1 G for Ao and aN.
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arrangements are shown in Fig. S6–8.† As expected based on
their structural similarity, the X-ray diﬀraction studies reveal a
similar bidentate (N,O−) 8-quinolinolato coordination mode
for copper(II) complexes of Q-3 and Q-4 and the reference com-
pound Q-1.44 Despite a coordination with the same donor
atom set, the copper(II) complex of Q-2 adopts a cyclic dimer
[(Cu(HQ-2)2)2]
4+ form, in which the phenolato oxygen acts as a
bridging atom between two metal centers of the neighboring
complexes (Fig. S6†). However, the presence of long inter-
molecular contacts Cu1⋯O11A or Cu1A⋯O11 (Å) strongly
suggests the weak association of complexes into dimers, which
most probably dissociate in aqueous solution with the for-
mation of monomeric species.
[(Cu(HQ-2)2)2]·(CH3OH)2·Cl4·(H2O)2 crystallized in the
monoclinic C2/c space group (Fig. 5 and S6†). The ligand in
this complex is in the neutral zwitterionic HL form (with
phenolate-O− and morpholinium-NH+). The metal ion is co-
ordinated in a square-pyramidal mode, with the basal plane
defined by atoms O1 and N1 from one Q-2 ligand and O11 and
N21 from another Q-2 ligand in the trans position to each
other, while atom O11 from another bis complex occupies the
axial position of the metal ion (and vice versa) with a long
Cu1–O11 distance (2.681(3) Å). The complex has an inversion
centre symmetry, half of the molecule can be found in the
asymmetric unit. The charge of the complex is neutralized by
chloride counter ions. It is worth mentioning that the
O33 atom of a neighbouring morpholine ring comes closer at
a distance of 2.810(3) Å to the second axial position of the
copper atom (Fig. S6†). The copper–copper distance is
3.3935(7) Å in the dimeric complex. The complex structure is
further stabilized by two intramolecular hydrogen bonds
C22–H22⋯O1 and C29–H29B⋯O1, and the main inter-
molecular interactions are listed in Table S9.†
[Cu(Q-3)2]·Cl2 crystallized in the monoclinic crystal system,
in the space group P21/n (Fig. 5 and S7†). The ligand shows a
bidentate (N,O−) coordination mode forming a square planar
type geometry around the copper center. The planar arrange-
ment of the two quinolinolato rings is also secured by the
intramolecular hydrogen bond of C2–H2⋯O1. In addition to a
N–H⋯Cl bond and three weak C–H⋯Cl hydrogen bonds, π⋯π
intermolecular interactions stabilize the crystal lattice between
the neighboring quinoline moieties (Fig. S7 and Table S10†).
The closest copper–copper distance is 6.534(5) Å in this
structure.
[Cu(HQ-4)2(CH3OH)]·ZnCl4·CH3OH crystallized in the tri-
clinic crystal system, space group P1ˉ (Fig. 5 and S8†). The two
HL ligands are coordinated via the (N,O−) donor set resulting
in a square planar geometry. The fifth (axial) coordination
position is occupied by a methanol-OH group with a Cu1–O3
distance of 2.314(4) Å. Although the copper–copper distance
(3.8354(8) Å) is significantly larger than in the crystal
[Cu(Q-3)2]·Cl2 the arrangement of the pair of complexes is very
similar to it, and the complexes are placed face to face with
their parallel basal planes such as O2 is arranged in the axial
position of a neighboring copper ion (and vice versa, see
Fig. S8†). Intra- and intermolecular interactions can be found
in Table S11.†
Correlations between solution equilibrium constants and
in vitro cytotoxicity
While the low number of the compounds did not allow statisti-
cally valid conclusions, we attempted to correlate the solution
equilibrium properties of the studied 8-hydroxyquinolines
with their biological activity. Correlations between the in vitro
cytotoxicity (pIC50) obtained in the MES-SA/Dx5 cancer cell line,
lipophilic character (logD7.4), proton dissociation constants
Fig. 5 The cyclic dimer structure of the complex cations [(Cu(HQ-2)2)2]
4+ in [(Cu(HQ-2)2)2]·(CH3OH)2·Cl4·(H2O)2 (a), [(Cu(Q-3)2]
2+ in [Cu(Q-3)2]·Cl2
(b) and [(Cu(HQ-4)2(CH3OH)]
2+ in [Cu(HQ-4)2(CH3OH)]·ZnCl4·CH3OH (c) at the 30% probability level of displacement ellipsoids. Hydrogens, as well
as the chloride and [ZnCl4]
2− anions, water and methanol molecules present in the crystal lattice are omitted for clarity. Selected bond lengths (Å)
and angles (°) for [(Cu(HQ-2)2)2]
4+: Cu1–O1 1.931(3), Cu1–O11 1.954(3), Cu1–N1 1.989(3), Cu1–N21 1.967(3), Cu1–O11A 2.681(3), O1–Cu1–O11
179.5(1), N1–Cu1–N21 171.0(1), O1–Cu1–N1 84.2(1), O1–Cu1–N21 95.7(1), O11A–Cu1–N1 92.8(1), O11A–Cu1–N21 96.1(1), O1–Cu1–O11A 92.4(1),
O11–Cu1–O11A 87.2(1). Selected bond lengths (Å) and angles (°) for [(Cu(Q-3)2]
2+: Cu2–O1 1.945(6), Cu2–N1 1.951(8), O1–Cu2–N1 85.1(3),
O1–Cu2–N1 94.9(3), O1–Cu2–O1 180.0, N1–Cu2–N1 180.0. Selected bond lengths (Å) and angles (°) for [(Cu(HQ-4)2(CH3OH)]
2+: Cu1–O1 1.969(2),
Cu1–O2 1.952(3), Cu1–N1 1.989(4), Cu1–N21 1.978(4), Cu1–O3 2.314(4), O1–Cu1–O2 174.53(13), N1–Cu1–N21 174.63(15), O1–Cu1–N1 84.26(11),
O1–Cu1–N21 97.11(11), O2–Cu1–N1 93.95(13), O2–Cu1–N21 84.22(13), O1–Cu1–O3 87.43(11), O3–Cu1–N1 97.45(14), O3–Cu1–N21 87.81(14),
O1–Cu1–O3 87.43(11).
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(pKa) of the compounds and their metal binding abilities
(pM values) were analyzed (Fig. 6). No relationship was found
between the pIC50 and log D7.4 values (Table 1 and Scheme 2)
suggesting that lipophilicity as a single parameter is not a pre-
dictor of cytotoxicity of the studied ligands, despite the often
well-established correlations between the biological activity
and lipophilicity of cytotoxic drug molecules, as the latter
strongly aﬀects membrane permeability. Whereas there was no
strong correlation between pIC50 and pKa (NquinolinidiumH
+)
values, cytotoxicity seemed to increase with lower pKa values of
the hydroxyl moiety (Fig. 6a and b). Furthermore, compounds
with weaker copper(II) and iron(III) binding abilities (at physio-
logical pH) seemed to be more toxic, as suggested by the
relationship of pM and pIC50 values (Fig. 6c and d). The more
cytotoxic Q-4 and Q-3 depending on the metal-to-ligand ratio
form positively charged complexes at pH 7.4 with both metal
ions (Q-4: [CuL2H]
+, [CuL]+ and [FeL2H]
2+; Q-3: [CuL2]
2+,
[CuL]2+ and [FeL2]
3+), while the less active compounds (Q-1
and Q-1) mostly form neutral complexes (Q-1: [CuL2], [CuL]
+
and [FeL3]; Q-2: [CuL2], [CuL2H]
+, [CuL]+ and [FeL3]).
Redox properties of the studied 8-hydroxyquinolines with
iron(III) and copper(II)
In addition to solution stability, the toxicity of metal complexes
is also influenced by their redox properties. We therefore
characterized the redox features of the copper(II) and iron(III)
complexes of the studied 8-hydroxyquinoline ligands. First, the
redox activity of iron(III) and copper(II) complexes was investi-
gated by cyclic voltammetry (CV). The CV measurements were
carried out in pure DMSO due to the low water solubility of
these metal complexes (c ≪ 0.5 mM). However, aprotic organic
solvents can modify complex formation processes and redox
properties. Reliable data could be collected only for the com-
plexes formed with Q-1 and Q-3, when quasi-reversible redox
processes were observed.
Representative voltammograms recorded for the complexes
formed with Q-3 at diﬀerent metal-to-ligand ratios are shown
in Fig. 7 and for the complexes formed with the other ligands
in Fig. S9.† The corresponding electrochemical data are
collected in Table S12.† Based on the voltammograms it could
be concluded that upon complex formation with Q-1 and Q-3,
the half-wave potentials (E1/2) are shifted to more negative
potentials compared to those of the corresponding metal salts.
(Ligands Q-3 and Q-2 were found to be redox active as well, but
their identified cathodic peaks appear at much lower poten-
tials than the peaks belonging to the metal complexes (Fig. S9
and Table S12†).) On the other hand, redox processes of the
copper(II/I) systems occur in lower potential ranges compared
to the iron containing systems. Interestingly, the observed
shifts from the half-wave potentials of the metal salts were
much larger in the case of ligand Q-1 as compared to Q-3 for
both metal ions. Thus, Q-3, the more cytotoxic ligand,
stabilizes the lower oxidation states of iron and copper more
than Q-1.
In comparison with the formal potential of −0.26 V
reported for the redox couple of oxidized glutathione/gluta-
thione (GSSG/GSH) at physiological pH,45 the determined E1/2
value of the iron-Q-3 complex is more positive (Table S12†),
suggesting that GSH might be able to reduce this iron(III)
complex, while the reduction of the iron(III) complex of Q-1 by
GSH seems unlikely based on these data. However, since the
CV data were obtained in DMSO solutions, care is warranted in
Fig. 7 Cyclic voltammograms of the iron(III)–Q-3 (a) and copper(II)–Q-3
(b) systems. The ligand alone (black/deprotonated: grey), FeCl3 (brown),
iron complexes at the M : L ratios 1 : 1 (bordeaux), 1 : 2 (red) and 1 : 3
(orange), as well as for CuCl2 (light blue), and copper complexes at the
M : L ratios 1 : 1 (blue) and 1 : 2 (green). (Potentials measured against
Ag/AgCl/KCl (3 M); cQ-3 = 1.0 mM; solvent: DMSO; I = 0.01 M (TBAClO4);
T = 25 °C; scan rate = 5 mV s−1).
Fig. 6 Correlations between pIC50 values measured in MES-SA/Dx5 cell
lines (IC50: mol L
−1) and pKa (OH) (a), pKa (NquinolinidiumH
+) (b), pFe(III)* (c)
and pCu(II) (d) of the studied 8-hydroxyquinolines. Data are taken from
Tables 1 and 2 and Scheme 2.
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extrapolating the obtained results to the intracellular milieu.
Therefore, the direct reactions of the iron(III) and copper(II)
complexes of Q-1 to Q-4 with two physiologically relevant
reducing agents GSH and ascorbate (ASC) were followed by
UV-Vis spectrophotometry under strictly anaerobic conditions.
Absorbance spectra were analyzed at λ > 310 nm, where
neither the reduced nor the oxidized forms of GSH and ASC
absorb light.46,47
No significant spectral changes were observed upon reac-
tion of the iron(III) complexes with 2.5 equivalents of GSH
(in HEPES buﬀer, pH 7.4) within a time frame of 90 min. It
was reported that the reduction of some iron(III)47 and
vanadium(V)46,48 complexes by GSH might be kinetically
hindered, while the dehydro-L-ascorbic acid/ASC redox pair
(E′° at physiological pH = +0.05 V),49 reacts considerably faster.
Redox reactions of the iron(III) complexes with ASC were
observed at pH 6.87 as shown in Fig. S10,† although the spec-
tral changes were still minor under the conditions, especially
in the case of Q-3 and Q-4. Addition of H2O2 to the samples
reverses these changes.
Notably, the copper complexes have lower redox potentials
than the iron compounds (Table S12†), thus the copper(II)
complexes are less powerful oxidizing agents. Nevertheless,
copper(II) complexes of Q-1 to Q-4 show characteristic spectral
changes upon reaction with GSH, as displayed exemplarily for
the complex of Q-2 in Fig. 8. The significant decrease of the
absorbance values at the λmax of the copper(II) complex
occurred relatively fast, indicating a possible ligand release
from the reduced copper(I) complex. In order to assess
whether the observed reduction process of the copper(II)
complex is reversible, H2O2 was added to the samples at the
end of the reaction. Upon addition of the oxidizing agent the
spectrum of the original copper(II) complex reappeared, indi-
cating the reversibility of the redox process and the possibility
of an intracellular redox-cycling reaction. The time courses of
the spectral changes induced by the reaction of the various
copper(II) complexes with GSH are compared in Fig. S11.† The
observed rate constants (kobs) of the redox reactions, calculated
based on the initial slope of the ln(A/A0) vs. t plots
(not shown), were as follows: 0.15 min−1 for Q-1, 0.21 min−1
for Q-2, 0.20 min−1 for Q-3, and 0.02 min−1 for Q-4. This trend
indicates that a stronger copper(II) binding ability of the
ligands is accompanied by the faster redox reaction of their
complex with GSH. Despite the trend in the kinetics of the
reduction of the copper complexes, showing the slowest reac-
tion for the most toxic ligand, a clear quantitative relationship
could not be established between the redox chemical charac-
teristics and the cytotoxic activity of the compounds.
Conclusions
8-Hydroxyquinoline derived Mannich bases were shown to
exhibit high potency against human cancer cell lines, and the
importance of a CH2–N building block at position 7 has also
been described.27 As the biological activity of a chelator can be
aﬀected by the lipophilicity, pKa values, metal binding abilities
and redox properties of the forming complexes, the possible
relationship between these parameters was monitored in
detail in the case of 8-hydroxyquinoline (Q-1) and its three
derivatives containing the crucial CH2–N moiety. Due to the
protonated tertiary amine nitrogens in 7-(morpholinomethyl)
quinolin-8-ol (Q-2) and 7-(piperidin-1-ylmethyl)quinolin-8-ol
(Q-3), the hydrophilicity is increased as compared to Q-1, while
the newly synthesized and characterized 5-chloro-7-((2-fluoro-
benzylamino)methyl)quinolin-8-ol (Q-4) possesses a more lipo-
philic character. In addition, the various substitutions of the
Q-1 scaﬀold altered the size, the acid–base character, charges
and the metal ion chelation of the compounds. To evaluate
the eﬀect of these alterations on the in vitro anticancer activity
of the compounds, cytotoxicity of Q-1 to Q-4 was tested against
the drug resistant human uterine sarcoma MES-SA/Dx5 cell
line as well as against primary hepatocytes. All compounds
showed marked cytotoxic activity (IC50 values 0.20–3.27 μM) in
the cancer cells increasing in the following order Q-2 < Q-1 <
Q-3 < Q-4. IC50 values obtained in primary hepatocytes
revealed a much better selectivity of the studied compounds
towards cancer cells than the chemotherapy agent doxo-
rubicin. Even though the most lipophilic derivative Q-4 was
found to be the most toxic, no clear relationship was apparent
between the lipophilicity of the set of derivatives and their tox-
icity, suggesting that the cytotoxicity of the compound series is
not strictly dependent on membrane permeability.
Fig. 8 Time-dependent UV-Vis spectra of the copper(II) complexes of
Q-2 (a) upon addition of 2.5 equivalents of GSH at pH 7.40. The black
dashed lines denote the initial spectra before the addition of GSH and
the red dashed lines denote the spectra upon addition of H2O2 (a).
Absorbance values measured at 370 nm plotted against the time
(b). (ccopper(III) = 100 μM; cligand = 100 μM; cGSH = 250 μM; T = 25.0 °C;
I = 0.20 M KCl).
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Relationship between proton dissociation constants and
cytotoxicity
Based on the determined pKa values, the compounds predomi-
nate in their neutral forms at physiological pH, although Q-3
and Q-4 are mostly present in their zwitterionic L and HL
forms, respectively. As compared to Q-1, the pKa values of the
quinolinium-NH+ decrease due to the electron withdrawing
eﬀect of the various substituents in Q-2 to Q-4, and the pKa of
the phenolic-OH moiety is reduced in Q-3 and Q-4. On the
other hand, the morpholino substituent in the 7-position
increases the pKa (OH) as a consequence of an intramolecular
hydrogen bond between the OH and the morpholine-N in the
HL form of the ligand. Interestingly, formation of intra-
molecular hydrogen bonding is also feasible in the solid Q-3
and Q-4·HCl·H2O according to their single crystal X-ray diﬀrac-
tion analysis. It was concluded that compounds with lower
pKa (OH) values possess lower IC50 values in the MES-SA/Dx5
cancer cell lines showing a linear relationship.
Solution speciation and solid structures of the complexes
Formation of mono and bis complexes with copper(II) and iron
(III) was found based on the UV-visible spectrophotometric
titrations, whereas tris iron(III) complexes could also be
detected for two of the ligands. At physiological pH, the
copper(II) binding strength of the studied compounds follows
the order Q-2 > Q-1 > Q-3 > Q-4 and a similar trend was deter-
mined for the iron(III) complexes (Q-1 ∼ Q-2 > Q-3 > Q-4). The
studied 8-hydroxyquinolines have a binding preference to
copper(II) over iron(III) at pH 7.4. Results of the EPR spectro-
scopic measurements and the solid phase structures of
[(Cu(HQ-2)2)2]·(CH3OH)2·Cl4·(H2O)2, [Cu(Q-3)2]·Cl2 and
[Cu(HQ-4)2(CH3OH)]·ZnCl4·CH3OH characterized by single-
crystal X-ray diﬀraction analysis confirmed the coordination
via the (N,O) donor set in the copper(II) complexes.
Relationship between solution stability, redox properties and
cytotoxicity
In the investigated set of compounds, those possessing weaker
copper(II) and iron(III) binding abilities at physiological pH were
found to be more toxic against the cancer cell line. Based on the
cyclic voltammetric data of the iron and copper complexes, the
more cytotoxic Q-3 stabilizes the lower oxidation states of these
metal ions stronger than Q-1. Glutathione was not able to reduce
the iron(III) complexes of the tested 8-hydroxyquinolines at five-
fold excess within a time frame of 90 min, while copper(II) com-
plexes could be reduced much faster, and in a reversible manner.
The compounds with stronger copper(II) binding abilities showed
faster redox reactions and were found to be less cytotoxic.
In all, the established property–activity relationship for the
studied compounds can help in understanding the mechanism of
action of 8-hydroxyquinolines and can contribute to the develop-
ment of anticancer compounds. We found that the introduction of
the morpholine moiety at position 7 slightly reduced the cyto-
toxicity of 8-hydroxyquinoline in the MES-SA/Dx5 cell line, at the
same time the piperidine and fluorobenzylamino substituents
(with chlorine at position 5) increased the activity. The morpholine
derivative has slightly higher, while the latter two compounds have
much lower pKa (OH) than the reference compound Q-1. The more
cytotoxic ligands possess weaker iron(III) and copper(II) binding
abilities than Q-1. Based on these conclusions, Q-4 was selected as
a candidate for undergoing preclinical in vivo experiments.
Experimental section
Chemicals
Solid KOH, 8-hydroxyquinoline (Q-1), 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES), tetrabutylammonium
chloride (TBACl), ferrocene, 5-chloroquinolin-8-ol, 2-fluoro-
benzylamine, paraformaldehyde, ascorbic acid (ASC) and
glutathione (GSH) were purchased from Sigma-Aldrich and HCl,
KCl, CuCl2, FeCl3, and n-octanol were Reanal products
(Budapest, Hungary). Q-2 (NSC662298) and Q-3 (NSC57969) were
acquired from the drug repository of the Developmental
Therapeutics Program of the National Cancer Institute. Iron(III)
and copper(II) stock solutions were prepared by dissolving appro-
priate amounts of metal chlorides in known amounts of HCl.
Their concentrations were determined by complexometry via
EDTA complexes. Accurate strong acid content of the metal stock
solutions was determined by pH-potentiometric titrations. The
studied 8-hydroxyquinolines were poorly soluble in water; there-
fore stock solutions (0.01 M; 1.4–3.7 g L−1) were in pure DMSO.
Solubility in water was not determined experimentally, but based
on the determined log D7.4 values we can conclude that Q-2
and Q-3 have somewhat better, while Q-4 has definitely a worse
(∼50 μM) water solubility than Q-1 (S ∼ 0.56 g L−1, ∼4 mM). (The
solubility of these compounds strongly depends on the pH.)
Chemicals used for the synthesis were of reagent grade quality
or better, obtained from commercial suppliers and used without
further purification. Solvents were used as received or dried.
Synthesis and characterization of 5-chloro-7-((2-fluorobenzyl-
amino)methyl)quinolin-8-ol hydrochloride (Q-4·HCl)
Q-4·HCl was obtained by the acidic cleavage of 5-chloro-3-
(2-fluorobenzyl)-3,4-dihydro-2H-[1,3]oxazino[5,6-h]quinoline,
which was prepared by the reaction of 5-chloroquinolin-8-ol
(0.50 g, 2.78 mmol), 2-fluorobenzylamine (0.52 g, 4.15 mmol)
and paraformaldehyde (0.208 g, 6.95 mmol) using ethanol
(17 mL) as the solvent in a 35 mL pressurized reaction vial.
The mixture was heated by microwave irradiation at 100 °C for
45 min. The solvent was then evaporated oﬀ and the residue
was crystallized with n-hexane : ethyl acetate (5 : 1; 30 mL) and
recrystallized from 20 mL of diisopropyl ether. Yield: 0.795 g
(87%); mp.: 150–152 °C. 1H NMR (DMSO-d6, Fig. S12†): δ =
3.96 (2H, s); 4.08 (2H, s); 5.11 (2H, s); 7.12–7.26 (2H, m); 7.36
(1H, t, J = 7.6 Hz); 7.41–7.52 (2H, m); 7.65 (1H, dd, J = 8.12 Hz,
3.84 Hz); 8.46 (1H, d, J = 8.5 Hz); 8.92 (1H, s); 13C NMR
(DMSO-d6, Fig. S13†): δ = 48.3; 48.7; 61.7; 115.2; 115.4; 118.6;
120.1; 122.5; 124.4; 124.9; 125.0; 126.4; 129.4; 131.1; 132.2;
139.4; 148.8; 149.9. Anal. calcd for C18H14ClFN2O (328.77): C,
65.76; H, 4.29; N, 8.52. Found: C, 66.02; H, 4.31; N, 8.49.
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To obtain Q-4·HCl 0.15 mL (1.0 mmol) of HCl/ethanol
(22%) was added to a stirred solution of 5-chloro-3-(2-fluoro-
benzyl)-3,4-dihydro-2H-[1,3]oxazino[5,6-h]quinoline (0.20 g;
0.6 mmol) in ethanol (15 mL). The mixture was stirred for
30 min at room temperature. After the evaporation of the
solvent and crystallization with diethyl ether (10 mL), the
product was obtained in 91% yield (0.19 g); mp.: 211–213 °C.
1H NMR (DMSO-d6, Fig. S14†): δ = 4.25 (2H, s); 4.37 (2H, s);
7.22–7.32 (2H, m); 7.43–7.53 (1H, m); 7.75 (1H, t, J = 7.2 Hz);
7.81 (1H, dd, J = 8.24 Hz, 3.97 Hz ); 8.00 (1H, s); 8.56 (1H, d, J =
8.2 Hz); 9.02 (1H, s); 9.85 (2H, brs); 13C NMR (DMSO-d6,
Fig. S15†): δ = 43.0; 44.1; 114.9; 115.6; 118.4; 119.0; 119.1;
123.8; 124.6; 126.2; 129.4; 131.5; 132.5; 133.0; 138.4; 149.3;
151.9. Anal. calcd for C17H15Cl2FN2O (353.22): C, 57.81; H,
4.28; N, 7.93. Found: C, 57.92; H, 4.27; N, 7.95.
1H and 13C NMR spectra were recorded in deuterated sol-
vents on a 400 (1H: 400 MHz, 13C: 100.6 MHz) MHz spectro-
meter at room temperature. Chemical shifts δ are expressed in
ppm values using the residual solvent peaks as internal stan-
dards (DMSO-d6 2.50; 39.52 ppm).
50 Melting points were deter-
mined on a Hinotek X-4 type melting point apparatus and are
uncorrected. Elemental analyses were performed with a
PerkinElmer 2400 CHNS elemental analyzer. Merck Kieselgel
60F254 plates were used for TLC. Microwave reactions were per-
formed by using a CEM LabMate microwave reactor.
Crystallization, X-ray data collection, structure solution and
refinement
Single crystals suitable for X-ray crystallography (SXRD) (Q-3,
Q-4·HCl·H2O, [(Cu(HQ-2)2)2]·(CH3OH)2·Cl4·(H2O)2, [Cu(Q-3)2]·Cl2
and [Cu(HQ-4)2(CH3OH)]·ZnCl4·CH3OH) were grown from slow
evaporation of a methanolic solution at room temperature. In
the case of the crystallisation of the copper complexes the solu-
tion contained the metal ion and the ligand at a 1 : 2 ratio.
[Cu2(Q-2)4]·(CH3OH)2·(Cl)4·(H2O)2 and [Cu(Q-3)]·(Cl)2 were crys-
tallized from methanolic solutions applying vapour diﬀusion of
diethyl ether to reduce the solubility. The complex of Q-4 could
not be crystallized under similar conditions, however when
ZnCl2 was also present in the solution the crystals of
[Cu(Q-4)]·(ZnCl4)·(CH3OH) could be obtained. As Cu and Zn
could not be unambiguously distinguished by SXRD, elemental
analysis (ICP-OES) has been performed. This crystal contains
2.6(1) mg kg−1 of Cu and 4.0(2) mg kg−1 of Zn that is a 60/40%
Zn/Cu ratio (with an error of ±5%). If we suppose that in this
crystal, Zn is possibly in a tetrahedral ZnCl4 form (40%) and Cu
is complexed by the Q-4 ligand (40%), there is still 20% of Zn
shared, half in ZnCl4 and the other half possibly occupies the
position of copper in the Q-4 complex. It means an 80%
copper(II) and 20% zinc(II) occupation of the central metal posi-
tion of the organic ligand complex cation, which may be the
reason for the poor crystal quality, which prevented the refine-
ment of the metal occupancy on the weak quality SXRD data.
The single crystals were mounted on loops. X-ray diﬀraction
data were collected on a Rigaku RAXIS-RAPID II diﬀractometer
at room temperature (293 K) in the case of Q-3, Q-4·HCl·H2O,
[(Cu(HQ-2)2)2]·(CH3OH)2·Cl4·(H2O)2, and [Cu(Q-3)2]·Cl2, while
the temperature was 103 K during the measurement of
[Cu(HQ-4)2(CH3OH)]·ZnCl4·CH3OH. Numerical absorption
correction was carried out, except the last crystal where multi-
scan absorption correction has been applied using the soft-
ware CrystalClear.51
Sir201452 and SHELXL53 under WinGX54 software were used
for crystal structure solution and refinement, respectively. The
structures were solved by direct methods. The models were
refined by full-matrix least squares on F2. Hydrogen atoms were
included in structure factor calculations but they were not refined,
and their isotropic displacement parameters were approximated
from the U(eq) value of the atom they were bonded to. Refinement
of non-hydrogen atoms was carried out with anisotropic tempera-
ture factors. Selected bond lengths and angles of compounds
were calculated using PLATON software.55 The graphical represen-
tations were done by Mercury,56 and the editing of CIF files was
performed using PublCif57 software, respectively.
Crystallographic data for the crystal structures were de-
posited at the Cambridge Crystallographic Data Centre as sup-
plementary publication numbers CCDC 1575107–1575111† for
the five crystals listed above.
UV-Vis spectrophotometry and determination of the
distribution coeﬃcients
The pH-metric measurements for determination of the exact
concentrations of HCl and KOH stock solutions used for the
spectrophotometric titrations were carried out at 25.0 ± 0.1 °C
in aqueous solutions and at an ionic strength of 0.20 M KCl in
order to keep the activity coeﬃcients constant. All the titra-
tions were performed with carbonate-free KOH solutions of a
known concentration (0.10 M) in the presence of 0.1 M KCl.
An Orion 710A pH-meter equipped with a Metrohm combined
electrode (type 6.0234.100) and a Metrohm 665 Dosimat
burette were used for titrations. The electrode system was cali-
brated to the pH = −log[H+] scale by the method suggested by
Irving et al.58 The average water ionization constant, pKwater, is
13.76 ± 0.01 at 25 °C. The samples were deoxygenated by bub-
bling purified argon for ca. 10 min prior to the measurements
and argon was also passed over the solutions during further
titrations. A Hewlett Packard 8452A diode array spectrophoto-
meter was used to record the UV-Vis spectra in the
200–800 nm interval. The path length was 1 or 2 cm. The spec-
trophotometric titrations were performed on the samples of
the ligands Q-3, Q-4 and Q-2 alone or with iron(III) or
copper(II). The concentration of the ligand was usually 50 µM
(10 µM for Q-4 due to its worse water solubility) and the metal
ion-to-ligand ratios were 1 : 1, 1 : 2 and 1 : 3 over the pH range
between 2 and 11.5 at an ionic strength of 0.20 M (KCl) at
25.0 ± 0.1 °C. The initial volume of the samples was 10.00 mL.
The samples contained 0.5% (v/v) DMSO. The overall protona-
tion constants of the ligands (from which the pKa values were
calculated), the overall stability constants of their metal
complexes and the individual spectra of the species were com-
puted using the program PSEQUAD59 and literature data were
used for iron(III) hydroxido species.60
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β(MpLqHr) is defined for the general equilibrium pM + qL +
rH ⇌ MpLqHr as β(MpLqHr) = [MpLqHr]/[M]
p[L]q[H]r where M
denotes the metal ion and L the completely deprotonated
ligand.
The n-octanol/water distribution coeﬃcients (logD7.4) of
the ligands Q-3, Q-4 and Q-2 were determined by the shake-
flask method in n-octanol/water solutions at 25.0 ± 0.2 °C at
pH 7.40 as described previously.16
EPR measurements
The EPR spectra were recorded at room temperature and at
77 K (in a Dewar flask containing liquid nitrogen) using a
BRUKER EleXsys E500 spectrometer (microwave frequency 9.81
GHz, microwave power 13 mW, modulation amplitude 5 G,
and modulation frequency 100 kHz). All EPR spectra were
simulated by a spectral decomposition method using the
“EPR” program.61 Since the copper(II) salt used to make the
stock solution was a natural mixture of isotopes, the spectrum
of each species was calculated as the sum of spectra contain-
ing 63Cu and 65Cu weighted by their natural abundances. The
copper and ligand coupling constants are given in units of
gauss (1 G = 10−4 T). The EPR spectra of the dimeric complex
was simulated using a new module of the ‘EPR’ program61
developed for calculating the EPR spectra and dynamic
nuclear polarization (DNP) in coupled spin systems (biradicals
and paramagnetic dimers). The EPR spectrum is calculated by
the complete diagonalization of the Hamiltonian of a two-spin
system. The details of the simulation was published
previously.62
Cyclic voltammetric measurements
All cyclic voltammograms of the iron(III) and copper(II) com-
plexes were measured in DMSO (with a H2O content of up to
1.6% for copper samples and 3.7% for iron samples) at 25.0 ±
0.1 °C and at an ionic strength of 10 mM (TBAClO4). Samples
contained 1.0 mM metal ion or 1.0 mM ligand (Q-1, Q-2, Q-3,
Q-4) alone or together while the cL/cM ratios were 1, 1.5, 2 or
3. Measurements were performed on a conventional three-elec-
trode system under an argon atmosphere and a PC controlled
Autolab-PGSTAT 204 potentiostat. Samples were purged for
15 min with argon before recording the cyclic voltammograms.
A glassy carbon electrode was used the working electrode, a
platinum electrode as the auxiliary electrode and a Ag/AgCl/
KCl (3 M) as the reference electrode. Electrochemical poten-
tials were converted into the normal hydrogen electrode (NHE)
scale by adding 0.210 V.63 The electrochemical measuring
system was calibrated with ferrocene in 95% (v/v) DMSO–water
(E1/2 = +0.50 ± 0.03 V vs. Ag/AgCl/KCl (3 M) in our setup).
Redox potentials were obtained at 5 mV s−1 scan rate in the
range of −1.2 to +1.0 V.
Reduction by GSH and ASC
Reduction of the copper(II) and iron(III) complexes of the
ligands Q-1 to Q-4 by GSH and ASC, respectively, was studied
by UV-Vis spectrophotometry using a Hewlett Packard 8452A
diode array spectrophotometer. A special, tightly closed
tandem cuvette (Hellma Tandem Cell, 238-QS, path length:
1 cm) was used and the reactants were separated until the reac-
tion was triggered. Both isolated pockets of the cuvette were
completely deoxygenated by bubbling a stream of argon for
10 min before mixing the reactants. Spectra were recorded before
and immediately after mixing, and changes were followed for
90 min. One of the isolated pockets contained the reducing
agent at five times (GSH) and 2.5 times (ASC) higher concen-
trations than that of the metal ions. The other pocket contained
the metal ions (Cu(II); Fe(III): 100 µM) and ligands at a 1 : 1 metal-
to-ligand ratio. The pH of the solutions was adjusted to 7.40 by
50 mM HEPES buﬀer, or to 6.87 by a mixed acetate : PBS buﬀer
(ratio 1 : 4), and an ionic strength of 0.1 M (KCl) was applied at
25.0 ± 0.1 °C. At the end of the measurements cc. H2O2 (50 µL to
1.4 mL sample) was added to the samples.
Cell lines and culture conditions
The doxorubicin selected human uterine sarcoma MES-SA-Dx5
cell line was obtained from ATCC (MES-SA/Dx5: No.
CRL-1977™). The cells were cultivated in Dulbecco’s Modified
Eagle’s Medium (DMEM, Sigma Aldrich, Hungary), sup-
plemented with 10% fetal bovine serum, 5 mM glutamine, and
50 unit per mL penicillin and streptomycin (Life
Technologies). All cell lines were cultivated at 37 °C, 5% CO2.
For the preparation of primary mouse hepatocytes mouse
handling and experimental procedures were conducted in
accordance with the institutional guidelines for animal care
and use. 16 weeks old male C57BL/6 mice were anaesthetized
(20 mg kg−1 tiletamine, 20 mg kg−1 zolazepam, 12.5 mg kg−1
xylazine and 3 mg kg−1 butorphanol) and livers were perfused
with 75 mL oxygenized perfusion buﬀer (120 mmol L−1 NaCl,
5.4 mmol L−1 KCl, 0.9 mmol L−1 NaH2PO4, 26 mmol L
−1
NaHCO3, 5.6 mmol L
−1 glucose, pH 7.4) supplemented with
EGTA (0.5 mmol L−1), followed by a second perfusion with
75 mL perfusion buﬀer without EGTA. Collagenase digestion
was performed by 75 mL perfusion buﬀer supplemented with
2.5 mmol L−1 CaCl2 and 0.2 mg mL
−1 collagenase (C5138,
Sigma). The digested liver was taken out of the abdominal
cavity and minced using tweezers, thereby releasing the hep-
atocytes. The cells were washed in ice-cold sterile suspension
buﬀer (10 mmol L−1 HEPES, 142 mmol L−1 NaCl, 7 mmol L−1
KCl, pH 7.4), filtered through a 100 µm mesh membrane and
centrifuged for 4 min at 4 °C at 80 g. After one additional
washing step, dead cells were removed by Percoll (Sigma) cen-
trifugation. After checking their viability by trypan blue exclu-
sion staining, the cells were seeded on 96-well plates pre-
coated with 5 µg cm−2 collagen I (BD, 356234) at a density of
1.35 × 104 cells per well in Williams E medium (Gibco) sup-
plemented with hepatocyte thawing/plating supplement
(Gibco) and 10% FBS. The cells that did not attach were
removed by refreshing the culture medium after 1 h. The
medium was renewed every 24 h during the culture as well as
during the experiment (containing the dilutions of the tested
compounds).
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MTT and PrestoBlue viability assay
MTT viability assays were performed as described earlier with
minor modifications.47,64,65 Briefly, cells were seeded into
96-well tissue culture plates (Sarstedt, Newton, USA/Orange,
Braine-l’Alleud, Belgium) at a density of 5000 cells per well and
allowed to attach overnight. Test compounds were added to
achieve the required final concentration in a final volume of
100 µL per well. After an incubation period of 72 h, the super-
natant was removed and fresh medium supplemented with the
MTT reagent (0.083 mg mL−1) was added. Incubation with
MTT at 37 °C was terminated after 1 h by removing the super-
natants and lysing the cells with 100 µL DMSO per well.
Viability of the cells was measured spectrophotometrically by
absorbance at 540 nm using either a PerkinElmer Victor X3 or
an EnSpire microplate reader, respectively. Data were back-
ground corrected by subtraction of the signal obtained from
unstained cell lysates and normalized to untreated cells.
On primary mouse hepatocytes, Q-1 to Q-4 were measured
using the PrestoBlue assay (Life Technologies) as described
earlier.27 Briefly, after the incubation with the compounds for
72 h and removal of the supernatants, a diluted solution of the
PrestoBlue reagent (10%) was added to each well. After
incubation with the reagent for one hour at 37 °C emission
was measured at 579 nm upon excitation at 540 nm using a
PerkinElmer EnSpire microplate reader.
Curves were fitted using Prism software66 using the sigmoi-
dal dose–response model (comparing variable and fixed
slopes). Curve fit statistics were used to determine the concen-
tration of the test compound that resulted in 50% toxicity
(IC50).
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